Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 4/2019

02.05.2019 | Original Article

Performance Evaluation of Automated Immunohematology Analyzer IH-500 for Blood Bank Testing

verfasst von: Sang Hyuk Park, Jaewook Kim, Ji-Hun Lim, Joseph Jeong, Seon-Ho Lee

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

The automated immunohematology analyzer IH-500 (Bio-rad, Cressier FR, Switzerland) was developed recently for blood bank tests and this study evaluated performance of IH-500. 200 blood samples for ABO/Rh typing were collected. ABO/Rh typing results measured by IH-500 was compared with conventional manual methods. Antibody screening tests were performed with 100 samples using both IH-500 and the Ortho BioVue System, and results were compared. Antibody identification tests were conducted on 5 samples using both IH-500 and the Ortho BioVue System and results were compared. Crossmatching was performed with both IH-500 and conventional manual tube method using 4 patient serum samples and 10 blood cell donors, and 40 results were compared. Isoagglutinin titer of anti-A and anti-B was determined in 10 samples using both IH-500 and the automated analyzer Ortho AutoVue Innova and concordance rates were obtained. The concordance rates of ABO/Rh typing, antibody screening test, antibody identification test, and crossmatching between comparative manual methods and the IH-500 were all 100%. In the evaluation of isoagglutinin titer, 8 (80.0%) results out of 10 samples (80%) showed results within ± 1 titer between the IH-500 and the AutoVue Innova, which indicates the concordance rates of 80.0%. IH-500 reported results with two titers lower than Ortho AutoVue Innova in two samples. The IH-500 demonstrated good concordance rates and provided reliable results compared to comparative manual methods in the blood bank testing. IH-500 would be useful as a possible replacement for conventionally performed manual methods in blood bank testing.
Literatur
1.
Zurück zum Zitat Brown MR, Fritsma MG, Marques MB (2005) Transfusion safety: what has been done; what is still needed? MLO Med Lab Obs 37(11):20–24PubMed Brown MR, Fritsma MG, Marques MB (2005) Transfusion safety: what has been done; what is still needed? MLO Med Lab Obs 37(11):20–24PubMed
2.
Zurück zum Zitat Davies A, Staves J, Kay J, Casbard A, Murphy MF (2006) End-to-end electronic control of the hospital transfusion process to increase the safety of blood transfusion: strengths and weaknesses. Transfusion 46(3):352–364CrossRef Davies A, Staves J, Kay J, Casbard A, Murphy MF (2006) End-to-end electronic control of the hospital transfusion process to increase the safety of blood transfusion: strengths and weaknesses. Transfusion 46(3):352–364CrossRef
3.
Zurück zum Zitat Stainsby D, Jones H, Asher D, Atterbury C, Boncinelli A, Brand L et al (2006) Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 20(4):273–282CrossRef Stainsby D, Jones H, Asher D, Atterbury C, Boncinelli A, Brand L et al (2006) Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 20(4):273–282CrossRef
4.
Zurück zum Zitat Klouche M (2008) Editorial: impact of automation for testing in transfusion medicine and blood banking. Laboratoriumsmedizin 32(2):57–58CrossRef Klouche M (2008) Editorial: impact of automation for testing in transfusion medicine and blood banking. Laboratoriumsmedizin 32(2):57–58CrossRef
5.
Zurück zum Zitat Dada A, Beck D, Schmitz G (2007) Automation and data processing in blood banking using the ortho AutoVue® Innova System. Transfus Med Hemother 34:341–346CrossRef Dada A, Beck D, Schmitz G (2007) Automation and data processing in blood banking using the ortho AutoVue® Innova System. Transfus Med Hemother 34:341–346CrossRef
6.
Zurück zum Zitat Barkham TM (2004) Laboratory safety aspects of SARS at biosafety level 2. Ann Acad Med Singapore 33(2):252–256PubMed Barkham TM (2004) Laboratory safety aspects of SARS at biosafety level 2. Ann Acad Med Singapore 33(2):252–256PubMed
7.
Zurück zum Zitat Butch SH (2008) Automation in the transfusion service. Immunohematology 24(3):86–92PubMed Butch SH (2008) Automation in the transfusion service. Immunohematology 24(3):86–92PubMed
8.
Zurück zum Zitat Sandler SG, Langeberg A, Avery N, Mintz PD (2000) A fully automated blood typing system for hospital transfusion services. ABS2000 study group. Transfusion 40(2):201–207CrossRef Sandler SG, Langeberg A, Avery N, Mintz PD (2000) A fully automated blood typing system for hospital transfusion services. ABS2000 study group. Transfusion 40(2):201–207CrossRef
9.
Zurück zum Zitat Shin SY, Kwon KC, Koo SH, Park JW, Ko CS, Song JH et al (2008) Evaluation of two automated instruments for pre-transfusion testing: AutoVue Innova and Techno TwinStation. Korean J Lab Med 28(3):214–220CrossRef Shin SY, Kwon KC, Koo SH, Park JW, Ko CS, Song JH et al (2008) Evaluation of two automated instruments for pre-transfusion testing: AutoVue Innova and Techno TwinStation. Korean J Lab Med 28(3):214–220CrossRef
10.
Zurück zum Zitat Schoenfeld H, Pretzel KJ, von Heymann C, Neuner B, Kalus U, Kiesewetter H et al (2010) Validation of a hospital-laboratory workstation for immunohematologic methods. Transfusion 50(1):26–31CrossRef Schoenfeld H, Pretzel KJ, von Heymann C, Neuner B, Kalus U, Kiesewetter H et al (2010) Validation of a hospital-laboratory workstation for immunohematologic methods. Transfusion 50(1):26–31CrossRef
11.
Zurück zum Zitat Taylor J, Hyare J, Stelfox P, Williams M, Lees R, Maley M (2011) Multi-centre evaluation of pre-transfusional routine tests using 8-column format gel cards (DG Gel®). Transfus Med 21(2):90–98CrossRef Taylor J, Hyare J, Stelfox P, Williams M, Lees R, Maley M (2011) Multi-centre evaluation of pre-transfusional routine tests using 8-column format gel cards (DG Gel®). Transfus Med 21(2):90–98CrossRef
12.
Zurück zum Zitat Shin KH, Kim HH, Chang CL, Lee EY (2013) Economic and workflow analysis of a blood bank automated system. Ann Lab Med 33(4):268–273CrossRef Shin KH, Kim HH, Chang CL, Lee EY (2013) Economic and workflow analysis of a blood bank automated system. Ann Lab Med 33(4):268–273CrossRef
13.
Zurück zum Zitat Chang C, Brown M, Davies L, Pointon L, Brown R, Barker D (2014) Evaluation of Erytra® fully automated analyser for routine use in transfusion laboratory. Transfus Med 24(1):33–38CrossRef Chang C, Brown M, Davies L, Pointon L, Brown R, Barker D (2014) Evaluation of Erytra® fully automated analyser for routine use in transfusion laboratory. Transfus Med 24(1):33–38CrossRef
14.
Zurück zum Zitat Cheng YW, Wilkinson JM (2015) An experience of the introduction of a blood bank automation system (Ortho AutoVue Innova) in a regional acute hospital. Transfus Apher Sci 53(1):58–63CrossRef Cheng YW, Wilkinson JM (2015) An experience of the introduction of a blood bank automation system (Ortho AutoVue Innova) in a regional acute hospital. Transfus Apher Sci 53(1):58–63CrossRef
15.
Zurück zum Zitat Roback JD, Barclay S, Moulds JM, Denomme GA (2015) A multicenter study on the performance of a fully automated, walk-away high-throughput analyzer for pretransfusion testing in the US population. Transfusion 55:1522–1528CrossRef Roback JD, Barclay S, Moulds JM, Denomme GA (2015) A multicenter study on the performance of a fully automated, walk-away high-throughput analyzer for pretransfusion testing in the US population. Transfusion 55:1522–1528CrossRef
16.
Zurück zum Zitat Shin JW, Shin WY, Lee DL (2017) Comparison of ABO blood group typing between automated blood bank analyzer IH-500 and manual method. Korean J Blood Transfus 28(2):126–133CrossRef Shin JW, Shin WY, Lee DL (2017) Comparison of ABO blood group typing between automated blood bank analyzer IH-500 and manual method. Korean J Blood Transfus 28(2):126–133CrossRef
17.
Zurück zum Zitat Park YM, Kim SY, Koo SH, Lim J, Kim JM, Lim YA (2017) Evaluation of the automated blood bank systems IH-500 and VISION max for ABO-RhD blood typing and unexpected antibody screening. Lab Med Online 7(4):170–175CrossRef Park YM, Kim SY, Koo SH, Lim J, Kim JM, Lim YA (2017) Evaluation of the automated blood bank systems IH-500 and VISION max for ABO-RhD blood typing and unexpected antibody screening. Lab Med Online 7(4):170–175CrossRef
18.
Zurück zum Zitat Morelati F, Revelli N, Maffei LM, Poretti M, Santoro C, Parravicini A (1998) Evaluation of a new automated instrument for pretransfusion testing. Transfusion 38(10):959–965CrossRef Morelati F, Revelli N, Maffei LM, Poretti M, Santoro C, Parravicini A (1998) Evaluation of a new automated instrument for pretransfusion testing. Transfusion 38(10):959–965CrossRef
Metadaten
Titel
Performance Evaluation of Automated Immunohematology Analyzer IH-500 for Blood Bank Testing
verfasst von
Sang Hyuk Park
Jaewook Kim
Ji-Hun Lim
Joseph Jeong
Seon-Ho Lee
Publikationsdatum
02.05.2019
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 4/2019
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-019-01127-4

Weitere Artikel der Ausgabe 4/2019

Indian Journal of Hematology and Blood Transfusion 4/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.